ARCT — Arcturus Therapeutics Holdings Balance Sheet
0.000.00%
- $561.01m
 - $364.55m
 - $152.31m
 
- 47
 - 28
 - 97
 - 59
 
Annual balance sheet for Arcturus Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 463 | 370 | 392 | 292 | 237 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.13 | 3.37 | 2.76 | 32.1 | 3.97 | 
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 468 | 379 | 403 | 387 | 306 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8.56 | 11.3 | 45 | 40.9 | 36.2 | 
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 476 | 393 | 450 | 429 | 344 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 49.5 | 99.5 | 127 | 82 | 65.5 | 
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 79.9 | 165 | 180 | 151 | 103 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 397 | 228 | 270 | 279 | 241 | 
| Total Liabilities & Shareholders' Equity | 476 | 393 | 450 | 429 | 344 | 
| Total Common Shares Outstanding |